Joel Morris - Concepedia

Author

Joel Morris

National Cancer Institute ORCID

Also Known As

J MORRIS, J. C. Morris, J. Morris, Joel Morris

167

Publications

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research Frederick National Laboratory for Cancer Research Leidos (United States)National Cancer Institute

About

Joel Morris is an author at National Cancer Institute specializing in medicine, drug discovery, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	834
2	Natural Sciences	1	1	745
3	Biochemistry	1	1	745
4	Cell Biology	1	1	45
5	Chemical Biology	1	1	745

Joel Morris

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set William C. Reinhold, Margot Sunshine, Hongfang Liu, Cancer Research	2012	903
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib Junko Murai, Shar-yin N. Huang, Amèlie Renaud, Molecular Cancer Therapeutics Molecular PharmacologyMedicinal ChemistryBioorganic ChemistryCatalytic Parp InhibitionBiochemistry	2013	745
Comprehensive characterization of the Published Kinase Inhibitor Set Jonathan M. Elkins, Vita Fedele, M. Szklarz, Nature Biotechnology	2015	338
Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition Junko Murai, Yiping Zhang, Joel Morris, Journal of Pharmacology and Experimental Therapeutics	2014	278
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression Eric C. Polley, Mark W. Kunkel, David M. Evans, JNCI Journal of the National Cancer Institute	2016	164
ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses Rozenn Jossé, Scott E. Martin, Rajarshi Guha, Cancer Research	2014	162
Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression Beverly A. Teicher, Eric C. Polley, Mark W. Kunkel, Molecular Cancer Therapeutics	2015	64
Bromodomain and hedgehog pathway targets in small cell lung cancer Gurmeet Kaur, Russell Reinhart, Anne Monks, Cancer Letters Myc StatusPathologyPathway TargetsCancer BiologyTumor Biology	2015	45
NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses William C. Reinhold, Sudhir Varma, Fabrício G. Sousa, PLoS ONE Variant BurdenMolecular BiologyTranscriptomics TechnologyPharmacological Cellminer AnalysesSingle Cell Sequencing	2014	44
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent Beverly A. Teicher, Thomas Silvers, Michael Selby, Cancer Medicine	2017	21

Page 1